JPH0622559B2 - Porous chitin molding for hemostasis - Google Patents
Porous chitin molding for hemostasisInfo
- Publication number
- JPH0622559B2 JPH0622559B2 JP60194087A JP19408785A JPH0622559B2 JP H0622559 B2 JPH0622559 B2 JP H0622559B2 JP 60194087 A JP60194087 A JP 60194087A JP 19408785 A JP19408785 A JP 19408785A JP H0622559 B2 JPH0622559 B2 JP H0622559B2
- Authority
- JP
- Japan
- Prior art keywords
- chitin
- water
- porous
- present
- sponge
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229920002101 Chitin Polymers 0.000 title claims description 69
- 230000023597 hemostasis Effects 0.000 title claims 2
- 238000000465 moulding Methods 0.000 title description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 22
- 102000004169 proteins and genes Human genes 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 230000002439 hemostatic effect Effects 0.000 description 17
- 238000000034 method Methods 0.000 description 13
- 239000000126 substance Substances 0.000 description 12
- 239000003513 alkali Substances 0.000 description 11
- 229920003169 water-soluble polymer Polymers 0.000 description 11
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 8
- 238000001035 drying Methods 0.000 description 7
- 238000001179 sorption measurement Methods 0.000 description 7
- 229920001817 Agar Polymers 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 235000011121 sodium hydroxide Nutrition 0.000 description 6
- 239000008272 agar Substances 0.000 description 5
- 229920002451 polyvinyl alcohol Polymers 0.000 description 5
- 108010010803 Gelatin Proteins 0.000 description 4
- 239000004372 Polyvinyl alcohol Substances 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 239000012670 alkaline solution Substances 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 238000007127 saponification reaction Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000001112 coagulating effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000254173 Coleoptera Species 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- 125000003047 N-acetyl group Chemical group 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 206010041899 Stab wound Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000850 deacetylating effect Effects 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229940015043 glyoxal Drugs 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 239000002874 hemostatic agent Substances 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Description
【発明の詳細な説明】 (産業上の利用分野) 本発明は,新規な多孔性キチン成形体に関し,医療用具
などとして有用であり,従来のキチンスポンジと比較し
て特にタンパク吸着能力が高く,止血効果を備えている
点で外用止血用スポンジとして有用な止血用多孔性キチ
ン成形体に関するものである。DETAILED DESCRIPTION OF THE INVENTION (Field of Industrial Application) The present invention relates to a novel porous chitin molded article, which is useful as a medical device and the like, and has a particularly high protein adsorption ability as compared with a conventional chitin sponge. The present invention relates to a hemostatic porous chitin molded article useful as an external hemostatic sponge in that it has a hemostatic effect.
(従来の技術) 外用止血用スポンジとしては,ゼラチンスポンジが実用
化されている。ゼラチンは本来水溶性であるため,血液
や体液などにより湿潤すると速やかに溶解するため,ホ
ルムアルデヒド,ジアセチル,グリオキザールなどのタ
ンパク変性剤を用いて改質されたゼラチンスポンジが市
販されている。(Prior Art) A gelatin sponge has been put into practical use as an external hemostatic sponge. Since gelatin is inherently water-soluble, it dissolves quickly when wetted with blood or body fluids, so gelatin sponges modified with protein denaturants such as formaldehyde, diacetyl and glyoxal are commercially available.
従来から知られているキチンスポンジとしては,例え
ば,第1回国際キチン・キトサン会議記録集(Proceedin
g of the First International Confer-ence on Chitin
/Chitosan)第300頁,第16〜24行に,セルローズ
ビスコース法と同様な工程で得られたキチン溶液に硫酸
ナトリウムを混合した後,硫酸ナトリウムを溶出するス
ポンジの製造方法が記載されている。As a conventionally known chitin sponge, for example, the 1st International Chitin-Chitosan Conference Record Collection (Proceedin
g of the First International Confer-ence on Chitin
/ Chitosan) p. 300, lines 16-24, there is described a method for producing a sponge in which sodium sulfate is eluted after mixing a chitin solution obtained by a process similar to the cellulose viscose method with sodium sulfate. .
また,本発明者らは,キチン溶液に水溶性高分子物質を
添加混合し,その混合液を凝固して得られたキチン成形
体から水溶性高分子物質を溶出除去するという,湿潤強
度の高いキチンスポンジの製造方法を確立し,先に提案
した(特願昭59−176952号)。In addition, the inventors of the present invention have a high wet strength, in which a water-soluble polymer substance is added to and mixed with a chitin solution, and the mixture liquid is coagulated to elute and remove the water-soluble polymer substance from the obtained chitin molded body. A method for producing a chitin sponge was established and was previously proposed (Japanese Patent Application No. 59-176952).
(発明が解決しようとする問題点) 現在,実用化されている止血用ゼラチンスポンジは,湿
潤時の強度が低く,保形性も悪いという欠点があり,血
液や体液などで湿潤しても形態を保持できる堅牢な構造
をもつ止血用スポンジの開発が熱望されていた。(Problems to be solved by the invention) Currently used hemostatic gelatin sponges have the drawbacks of low strength when wet and poor shape retention. The development of a hemostatic sponge with a robust structure that can hold blood has been eagerly awaited.
一方,本発明者らが先に提案したキチンスポンジは,湿
潤時の強度も高いうえ,創傷治癒促進効果などの長所も
備えているが,止血効果は顕著ではなかった。したがっ
て,本発明の目的は,この堅牢な構造や,創傷治癒促進
効果などを損なうことなく,さらに止血効果をも兼ね備
えたキチンスポンジを提供することにある。On the other hand, the chitin sponge previously proposed by the present inventors has high strength when wet and has advantages such as a wound healing promoting effect, but the hemostatic effect was not remarkable. Therefore, an object of the present invention is to provide a chitin sponge that also has a hemostatic effect without impairing the robust structure and the effect of promoting wound healing.
(問題点を解決するための手段) 本発明者らは,止血作用をも兼ね備えた新規かつ有用な
キチンスポンジを得るべく鋭意検討の結果,多孔質キチ
ン成形体にアルカリ処理を施すことにより,タンパク吸
着能力が著しく増大するに伴い,止血作用が発現すると
いう事実を見出し,本発明を完成した。(Means for Solving the Problems) As a result of diligent studies to obtain a new and useful chitin sponge that also has a hemostatic action, the present inventors have found that the porous chitin molded body is treated with an alkali to obtain a protein. The present inventors have completed the present invention by discovering the fact that hemostatic action is manifested as the adsorptive capacity is significantly increased.
すなわち本発明は,水不溶のキチンからなる多孔質成形
体であって,乾燥成形体1gあたりのタンパク吸着量が
0.5mg以上であることを特徴とする止血用多孔性キチ
ン成形体である。That is, the present invention is a porous molded product for hemostatics, which is a porous molded product made of water-insoluble chitin and has a protein adsorption amount of 0.5 mg or more per 1 g of dried molded product.
本発明における水不溶のキチンとは,甲殻類,昆虫類等
を塩酸処理ならびにカ性ソーダ処理してタンパクおよび
カルシウム分を除去することにより得られるポリ(N−
アセチル−D−グリコサミン),あるいはそれらの誘導
体のうち水に溶解しないものをいう。かかるキチンの誘
導体としては,例えば,キチンのアセチルアミノ基の一
部が脱アセチルしたもの,エーテル化物,エステル化
物,ヒドロキシエチル化物,O−エチル化物等があげら
れ,具体例としてポリ〔N−アセチル−6−O−(2−
ヒドロキシエチル)−D−グリコサミン〕,ポリ〔N−
アセチル−6−O−(エチル)−D−グルコサミン〕等が
あげられる。The water-insoluble chitin in the present invention means poly (N-) obtained by treating crustaceans, insects, etc. with hydrochloric acid and caustic soda to remove proteins and calcium.
(Acetyl-D-glycosamine), or a derivative thereof that does not dissolve in water. Examples of such chitin derivatives include those obtained by partially deacetylating the acetylamino group of chitin, etherified products, esterified products, hydroxyethylated products, O-ethylated products, and the like, and specific examples include poly [N-acetyl]. -6-O- (2-
Hydroxyethyl) -D-glycosamine], poly [N-
Acetyl-6-O- (ethyl) -D-glucosamine] and the like.
本発明のタンパク吸着能力の優れたキチン成形体は,ま
ずキチンを多孔質に成形した後,その成形体にアルカリ
処理を施すことによって製造することができる。The chitin molded product of the present invention having excellent protein adsorption ability can be produced by first molding chitin into a porous material and then subjecting the molded product to alkali treatment.
本発明において多孔質とは,具体的には海綿状あるいは
スポンジ状であることを示し,乾燥状態で気孔率(B/
A×100:B;単位重量の多孔性成形体に含まれる細
孔の容積,A;単位重量の多孔性成形体の容積)が,好
ましくは80%以上,さらに好ましくは85%以上,最
適には90%以上であることを示す。キチンからなる多
孔性成形体を得るには,例えば以下のような方法が採用
できる。In the present invention, the term “porous” specifically means sponge-like or sponge-like, and the porosity (B /
A × 100: B; the volume of pores contained in the porous molded body of unit weight, A; the volume of the porous molded body of unit weight) is preferably 80% or more, more preferably 85% or more, optimally Indicates 90% or more. In order to obtain a porous molded body made of chitin, for example, the following method can be adopted.
すなわち,先ずキチンを溶剤に溶解してキチンドープを
得る。ここで溶剤とは公知のキチンの溶剤,例えば,ト
リクロル酢酸とハロゲン化炭化水素との混合物,塩化リ
チウムとN−メチルピロリドンとの混合物,または塩化
リチウムとジメチルアセトアミドとの混合物などが使用
できる。キチンドープ中のキチンの濃度は,使用するキ
チンの重合度により異なるが,好ましくは0.05〜5
0,さらに好ましくは0.1〜25,最適には0.3〜
10W/W %の範囲である。That is, first, chitin is dissolved in a solvent to obtain a chitin dope. Here, the solvent may be a known chitin solvent, for example, a mixture of trichloroacetic acid and a halogenated hydrocarbon, a mixture of lithium chloride and N-methylpyrrolidone, or a mixture of lithium chloride and dimethylacetamide. The concentration of chitin in the chitin dope varies depending on the degree of polymerization of chitin used, but is preferably 0.05-5.
0, more preferably 0.1 to 25, most preferably 0.3 to
It is in the range of 10 W / W%.
次に,キチンドープに水溶性高分子物質を添加し,分散
させる。ここで水溶性高分子物質とは,常温で固体であ
って、水に溶解可能な天然または合成の高分子物質のこ
とをいい,例えば,ポリビニルアルコール,ポリエチレ
ングライコール,ポリプロピレングライコール,寒天,
可溶性デンプン等が好ましく用いられるが,特にポリビ
ニルアルコール,寒天が好ましく用いられる。ポリビニ
ルアルコールとしては,低温または高温の水に溶解可能
であるケン化度が60モル%以上で,重合度が50〜2
000のものが好ましく用いられるが,さらには高温,
例えば60℃以上の水に溶解可能で,ケン化度が95モ
ル%以上のものが好ましく用いられる。寒天とは,テン
グサなど紅ソウ類の細胞膜成分として存在する粘質物ま
たはそれを凍結脱水して乾燥したもの,およびそれらか
ら分離したアガロース,アガロペクチンおよびその誘導
体を意味する。ポリプロピレングライコールやポリエチ
レングライコールとしては,分子量が1000以上のも
のが好ましく用いられる。これらの水溶性高分子物質
は,いずれも粉末の形で分散させて用いるのが好まし
い。これらの水溶性高分子物質は,前記キチンドープと
混合されるが,一般には水溶性高分子物質はキチンドー
プ中に溶解しないで,分散状態で存在させる。混合割合
は,重量比でキチンドープ/水溶性高分子=1/5〜5
/1の範囲が好ましい。Next, a water-soluble polymer substance is added to and dispersed in the chitin dope. Here, the water-soluble polymer substance refers to a natural or synthetic polymer substance that is solid at room temperature and is soluble in water, such as polyvinyl alcohol, polyethylene glycol, polypropylene glycol, agar,
Soluble starch and the like are preferably used, but polyvinyl alcohol and agar are particularly preferably used. Polyvinyl alcohol, which can be dissolved in water at low or high temperatures, has a saponification degree of 60 mol% or more and a polymerization degree of 50 to 2
000 is preferably used, but high temperature,
For example, those having a saponification degree of 95 mol% or more which can be dissolved in water at 60 ° C. or more are preferably used. The agar means a mucilage existing as a cell membrane component of red soup such as agar beetle or a substance obtained by freeze-drying and drying it, and agarose, agaropectin and derivatives thereof separated therefrom. As polypropylene glycol and polyethylene glycol, those having a molecular weight of 1000 or more are preferably used. It is preferable that all of these water-soluble polymer substances are used by being dispersed in the form of powder. These water-soluble polymer substances are mixed with the chitin dope, but generally, the water-soluble polymer substance does not dissolve in the chitin dope and is present in a dispersed state. The mixing ratio is chitin dope / water-soluble polymer = 1/5 to 5 by weight.
The range of / 1 is preferable.
以上のようにして得られた水溶性高分子物質が分散され
たキチンドープを、凝固液中に浸漬して成形凝固し,さ
らに水溶液にて処理して水溶性高分子物質を溶出除去し
て多孔性成形体が得られる。凝固液としては,水または
メタノール,エタノール,プロパノール,ブタノール等
のアルコール類,アセトン等のケトン類が好ましく使用
される。The chitin dope obtained by dispersing the water-soluble polymer substance obtained as described above is immersed in a coagulating liquid to be molded and coagulated, and then treated with an aqueous solution to elute and remove the water-soluble polymer substance to form a porous structure. A molded body is obtained. As the coagulating liquid, water or alcohols such as methanol, ethanol, propanol and butanol, and ketones such as acetone are preferably used.
凝固された成形体を処理する水溶性とは,水または少量
の塩類等を含んだ水を意味し,その処理温度および時間
は,水溶性高分子物質の水への溶解度に応じて選ばれる
が,一般には例えば80〜125℃の高温で1時間以上
の長時間にわたり処理する方法が好ましく用いられる。Water-soluble for treating a solidified molded article means water or water containing a small amount of salts, and the treatment temperature and time are selected depending on the solubility of the water-soluble polymer substance in water. Generally, for example, a method of treating at a high temperature of 80 to 125 ° C. for a long time of 1 hour or more is preferably used.
このようにして得られた多孔性成形体をアルカリ処理す
れば,本発明のキチン成形体が得られる。本発明におけ
るアルカリ処理とは,キチンからなる多孔性成形体とア
ルカリ溶液とが接触するようないかなる方法をも含む。
アルカリ溶液としては水酸化ナトリウム水溶液が実用的
であり,その濃度は好ましくは0.1w/v %以上,さら
に好ましくは10w/v%以上,最適には30〜60w/v%
の範囲であり,好ましい処理温度は10℃以上,さらに
好ましくは40℃以上,最適には60〜120℃の範囲
であればよい。処理時間はアルカリ濃度と処理温度とに
より異なるが,好ましくは1分〜24時間,さらに好ま
しくは15分〜12時間,最適には1〜6時間程度であ
ればよい。また浴比は,乾燥キチン成形体1重量部に対
しアルカリ溶液を好ましくは25重量部以上,さらに好
ましくは50重量部以上,最適には100重量部以上で
あればよい。アルカリ溶液は必要に応じて撹拌してもよ
く,処理後,アルカリを除去する場合には中和,水洗な
どの操作を行い,有機溶媒処理や乾燥を行ってもよい。
乾燥方法としては,自然乾燥,送風乾燥,真空乾燥など
の方法が採用できるが,乾燥による多孔性キチン成形体
の収縮を防ぐために,凍結乾燥法が好ましく用いられ
る。By subjecting the porous molded body thus obtained to alkali treatment, the chitin molded body of the present invention can be obtained. The alkali treatment in the present invention includes any method in which a porous molded body made of chitin is brought into contact with an alkaline solution.
An aqueous solution of sodium hydroxide is practical as an alkaline solution, and its concentration is preferably 0.1 w / v% or more, more preferably 10 w / v% or more, most preferably 30 to 60 w / v%.
The preferable treatment temperature is 10 ° C. or higher, more preferably 40 ° C. or higher, most preferably 60 to 120 ° C. The treatment time varies depending on the alkali concentration and the treatment temperature, but is preferably 1 minute to 24 hours, more preferably 15 minutes to 12 hours, and optimally 1 to 6 hours. The bath ratio is preferably 25 parts by weight or more, more preferably 50 parts by weight or more, and most preferably 100 parts by weight or more with respect to 1 part by weight of the dried chitin molding. The alkali solution may be stirred as necessary, and after the treatment, when removing the alkali, operations such as neutralization and washing with water may be carried out, followed by treatment with an organic solvent and drying.
As a drying method, a method such as natural drying, blast drying, or vacuum drying can be adopted, but a freeze-drying method is preferably used in order to prevent shrinkage of the porous chitin molded product due to drying.
このような方法によって得られた多孔性成形体は,乾燥
された多孔性キチン成形体1gあたりのタンパク吸着量
が,好ましくは0.5mg以上,さらに好ましくは1mg以
上,最適には2〜100mgであるというタンパクを吸着
する能力を備えている。ここでいうタンパク吸着量と
は,以下のような方法によって測定することができる。The porous molded product obtained by such a method has a protein adsorption amount of preferably 0.5 mg or more, more preferably 1 mg or more, optimally 2 to 100 mg per 1 g of dried porous chitin molded product. It has the ability to adsorb the protein that is present. The amount of adsorbed protein here can be measured by the following method.
細胞培養用仔牛血清を蒸溜水にて500倍に希釈して希
釈血清を調製し,この希釈血清20mlに対して検体1
00mgを添加して,37℃で10分間ゆるやかに撹拌し
た後の希釈血清中のタンパク濃度をAmg/mlとし,検
体を添加せずに同様に操作した場合のタンパク濃度をB
mg/mlとすると,(B−A)×20mgのタンパクが検
体100mgに吸着したことになる。The calf serum for cell culture is diluted 500 times with distilled water to prepare a diluted serum, and 20 ml of this diluted serum is used as a specimen 1
After adding 00 mg and gently stirring at 37 ° C for 10 minutes, the protein concentration in the diluted serum was set to Amg / ml, and the protein concentration in the case of performing the same operation without adding the sample was B.
If it is mg / ml, it means that (BA) × 20 mg of protein is adsorbed on 100 mg of the sample.
タンパク濃度は,フェノール試薬法(東京大学出版会発
行,生物化学実験法シリーズA−3,蛋白質の定量法,
第86〜103頁)によって定量すればよい。The protein concentration is determined by the phenol reagent method (published by The University of Tokyo Press, Biochemistry Experimental Method Series A-3, protein quantification method,
Pp. 86-103).
(実施例) 以下に実施例をあげ,本発明をさらに具体的に説明す
る。(Example) Hereinafter, the present invention will be described in more detail with reference to examples.
実施例1 キチン粉末(新日本化学製)を100メッシュに粉砕
し,1N−HClにて4℃で1時間処理し,さらに3%
NaOH水溶液にて90〜100℃で3時間処理して,
灰分栄よびタンパク質を除去し,水洗をくりかえし乾燥
して精製キチン粉末を得た。Example 1 Chitin powder (manufactured by Shin Nippon Chemical Co., Ltd.) was crushed to 100 mesh, treated with 1N-HCl at 4 ° C. for 1 hour, and further 3%.
Treat with NaOH aqueous solution at 90-100 ° C for 3 hours,
The ash content and protein were removed, and washing with water was repeated and drying was performed to obtain purified chitin powder.
精製キチン粉末2gを,LiCl8w/w %含むジメチル
アセトアミド98gに室温で溶解して透明なキチンドー
プを得た。このキチンドープに,ポリビニルアルコール
〔ポバールUF−170GS,ユニチカケミカル(株)
製,重合度170,ケン化度95モル%以上〕50gを
添加混合して,均一に分散させた。この分散液をガラス
板上に5cm四方,厚さ5mmに流延し,水道水中に浸漬し
てシート状に凝固させた。ガラス板から剥離後,十分量
の水に浸漬し,100℃で2時間の処理を水を交換しな
がら3回くりかえし,シート状の多孔質キチン成形体を
6枚得た。2 g of the purified chitin powder was dissolved in 98 g of dimethylacetamide containing 8% w / w of LiCl at room temperature to obtain a transparent chitin dope. To this chitin dope, polyvinyl alcohol [Poval UF-170GS, Unitika Chemical Co., Ltd.]
Manufactured, polymerization degree 170, saponification degree 95 mol% or more] 50 g was added and mixed, and uniformly dispersed. This dispersion was cast on a glass plate in a size of 5 cm square and a thickness of 5 mm, immersed in tap water and solidified into a sheet. After peeling from the glass plate, it was immersed in a sufficient amount of water, and the treatment at 100 ° C. for 2 hours was repeated 3 times while exchanging water to obtain 6 sheet-shaped porous chitin moldings.
このようにして得られたシートの水をよく絞り,1の
40w/v %NaOH水溶液に浸漬し,80℃にて5時間
処理した。冷却後,シートを約1の水中に移し,濃塩
酸にて中和した後,流水で洗浄し,さらに蒸溜水で洗浄
してから凍結乾燥して本発明のシート状キチン成形体を
得た。The sheet thus obtained was thoroughly squeezed with water, dipped in 40 w / v% NaOH aqueous solution of 1 and treated at 80 ° C. for 5 hours. After cooling, the sheet was transferred into about 1 water, neutralized with concentrated hydrochloric acid, washed with running water, further washed with distilled water, and then freeze-dried to obtain a sheet-shaped chitin molded article of the present invention.
得られたキチン成形体の乾燥成形体1gあたりのタンパ
ク吸着量は33mgで,湿潤時の引張り強度は13.5g
/mm2であり,気孔率は97%であった。The amount of protein adsorbed per 1 g of the dried molded product of the obtained chitin molded product was 33 mg, and the tensile strength when wet was 13.5 g.
/ Mm 2 , and the porosity was 97%.
実施例2 実施例1にて得られた精製キチン粉末2gを,LiCl
を8w/w%含むN−メチルピロリドン98gに溶解して
透明なキチンドープを得た。このキチンドープに寒天粉
末50gを添加混合して均一に分散させた。この分散液
を直径7mmの円形ノズルから加圧してメタノール中に押
出し,約5cmの長さに凝固させた後十分量の水に浸漬
し,120℃で30分間の処理を水を交換しながら3回
くりかえし,円柱状の多孔質キチン成形体を得た。Example 2 2 g of the purified chitin powder obtained in Example 1 was mixed with LiCl
Was dissolved in 98 g of N-methylpyrrolidone containing 8 w / w% to obtain a transparent chitin dope. To this chitin dope, 50 g of agar powder was added and mixed, and dispersed uniformly. This dispersion was pressurized from a circular nozzle with a diameter of 7 mm, extruded into methanol, solidified to a length of about 5 cm, immersed in a sufficient amount of water, and treated at 120 ° C. for 30 minutes while exchanging water. By repeating the process, a cylindrical porous chitin molded body was obtained.
このようにして得られたキチン成形体の水をよく絞り,
500mlの40w/v %NaOH水溶液に浸漬し,12
0℃にて1時間処理した。冷却後,スポンジを約1の
水中に移し,濃塩酸にて中和した後,流水で洗浄し,さ
らに蒸溜水で洗浄してから凍結乾燥して本発明の円柱状
キチン成形体を得た。Thoroughly squeeze the water of the chitin molded product obtained in this way,
Soak in 500 ml of 40 w / v% NaOH aqueous solution for 12
It was treated at 0 ° C. for 1 hour. After cooling, the sponge was transferred to about 1 water, neutralized with concentrated hydrochloric acid, washed with running water, further washed with distilled water, and then freeze-dried to obtain a cylindrical chitin molded product of the present invention.
得られたキチン成形体の乾燥成形体1gあたりのタンパ
ク吸着量は36mgで,湿潤時の引張り強度は12.8g
/mm2であり,気孔率は98%であった。The amount of protein adsorbed per 1 g of the dried molded product in the obtained chitin molded product was 36 mg, and the tensile strength when wet was 12.8 g.
/ Mm 2 , and the porosity was 98%.
実施例3〜7,比較例1 本発明のキチン成形体を得る際のアルカリ処理の条件
と,タンパク吸着量との関係を調べた。すなわち,実施
例1に記載した方法で得られたシート状の多孔質キチン
成形体をアルカリ処理するに際し,温度を120℃,時
間を60分間と固定し,NaOH水溶液の濃度を変えて
処理して得られたキチン成形体のタンパク吸着能力を測
定した。Examples 3 to 7 and Comparative Example 1 The relationship between the conditions of alkali treatment and the protein adsorption amount when obtaining the chitin molded product of the present invention was investigated. That is, when the sheet-like porous chitin molded body obtained by the method described in Example 1 was treated with alkali, the temperature was fixed at 120 ° C. and the time was fixed at 60 minutes, and the treatment was performed while changing the concentration of the NaOH aqueous solution. The protein adsorption capacity of the obtained chitin molded body was measured.
その結果,第1表に記載したように,処理する際のアル
カリ濃度の増加につれ,タンパク吸着量も増加すること
がわかる。As a result, as shown in Table 1, the amount of protein adsorbed increases with the increase of the alkali concentration during the treatment.
参考例1,2 従来のキチンスポンジと,本発明の多孔性キチン成形体
との止血効果を比較した。 Reference Examples 1 and 2 The hemostatic effects of the conventional chitin sponge and the porous chitin molded product of the present invention were compared.
従来のキチンスポンジとしては,実施例1において得ら
れたアルカリ処理を施していないシート状多孔質成形体
(タンパク吸着量:0.3mg/g)を用い,本発明の多
孔性キチン成形体としては,実施例1にて得られたもの
を用いた。As the conventional chitin sponge, the sheet-like porous molded article (protein adsorption amount: 0.3 mg / g) obtained in Example 1 which is not subjected to alkali treatment is used, and the porous chitin molded article of the present invention is The one obtained in Example 1 was used.
体重約2.5kgの家兎の背部の毛をそり,虫ピン10本
を直径約8mmに束ねた刺傷器を用いて,背筋表面を深さ
5〜6mmに突刺して出血させた。このような刺傷出血部
2ヶ所に,従来のキチンスポンジと本発明のものとを別
々に圧迫し,粘着テープで固定して,約2時間後出血に
よる着色部の面積を比較した。その結果,従来のキチン
スポンジは直径約35mmの円形に着色し,本発明の多孔
性キチンは直径約20mmの部分が着色したにとどまっ
た。Rabbits with a body weight of about 2.5 kg were shaved, and the back muscle surface was punctured to a depth of 5 to 6 mm using a puncture device in which 10 insect pins were bundled in a diameter of about 8 mm to cause bleeding. The conventional chitin sponge and that of the present invention were separately pressed against two such stab wounds and bleeding parts, fixed with adhesive tape, and after about 2 hours, the areas of the colored parts due to bleeding were compared. As a result, the conventional chitin sponge was colored in a circular shape having a diameter of about 35 mm, and the porous chitin of the present invention was colored only in a portion having a diameter of about 20 mm.
以上の結果より,本発明の多孔性キチン成形体は,未処
理のものと比較して止血効果に優れていることがわか
る。From the above results, it can be seen that the porous chitin molded product of the present invention is superior in the hemostatic effect as compared with the untreated product.
(発明の効果) 本発明の止血用多孔性キチン成形体は,堅牢な構造,優
れた生体適合性を有するとともに,これまでのキチンス
ポンジにはない止血作用を有するものである。その製造
方法は,キチンスポンジを作成して,これをアルカリ溶
液にて処理するという極めて簡便な操作であり,工業生
産にも適用可能である。(Effects of the Invention) The hemostatic porous chitin molded article of the present invention has a robust structure and excellent biocompatibility, and also has a hemostatic effect that is not present in conventional chitin sponges. The manufacturing method is an extremely simple operation of preparing a chitin sponge and treating it with an alkaline solution, and is applicable to industrial production.
本発明の止血用多孔性キチン成形体は,止血効果以外
に,接触した際の感触も処理前と比較して非常になめら
かであり,この点からも創傷カバー材として好適なもの
である。In addition to the hemostatic effect, the hemostatic porous chitin molded article of the present invention has a very smooth feel when contacted, as compared with that before treatment, and is also suitable as a wound cover material from this point.
Claims (1)
って,乾燥成形体1gあたりのタンパク吸着量が0.5mg
以上であることを特徴とする止血用多孔性キチン成形
体。1. A porous molded article composed of water-insoluble chitin, wherein the amount of protein adsorbed per 1 g of dried molded article is 0.5 mg.
The porous chitin molded body for hemostasis characterized by the above.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60194087A JPH0622559B2 (en) | 1985-09-02 | 1985-09-02 | Porous chitin molding for hemostasis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60194087A JPH0622559B2 (en) | 1985-09-02 | 1985-09-02 | Porous chitin molding for hemostasis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6253661A JPS6253661A (en) | 1987-03-09 |
| JPH0622559B2 true JPH0622559B2 (en) | 1994-03-30 |
Family
ID=16318737
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60194087A Expired - Lifetime JPH0622559B2 (en) | 1985-09-02 | 1985-09-02 | Porous chitin molding for hemostasis |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0622559B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007236551A (en) * | 2006-03-07 | 2007-09-20 | National Institute For Materials Science | Chitin derivative composite material and medical material |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6164256A (en) * | 1984-09-07 | 1986-04-02 | ユニチカ株式会社 | Wound covering protective material |
-
1985
- 1985-09-02 JP JP60194087A patent/JPH0622559B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6253661A (en) | 1987-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4543410A (en) | Absorbent cellulosic base structures | |
| US4405324A (en) | Absorbent cellulosic structures | |
| US4664105A (en) | Absorbing wound dressing and method for making the same | |
| EP0199531B1 (en) | Wound dressing | |
| US4501835A (en) | Polyacrylic acid/chitosan polyelectrolyte complex | |
| EP0171254B1 (en) | Shaped chitin body | |
| CN108409988B (en) | A kind of preparation method of spongy macroporous polyvinyl alcohol hydrogel | |
| CN107974831B (en) | Calcium alginate modified polypropylene fiber non-woven fabric and preparation method thereof | |
| CN110141677B (en) | Local acute hemostasis absorbable material and preparation method thereof | |
| WO2015103988A1 (en) | Medical dressing hydrogel composite fabric, and preparation method therefor and uses thereof | |
| CN101249275A (en) | A kind of wound dressing capable of isolating seawater and its preparation method | |
| JPS6390507A (en) | Chitosan sponge | |
| EP0176225B1 (en) | Porous chitin shaped article and production thereof | |
| CN118286489A (en) | Composite sponge based on carboxymethyl chitosan and sodium alginate, preparation method and application thereof | |
| JPS5823410B2 (en) | Hydrogel Youkizai | |
| CN115490911B (en) | Preparation method and application of medical polyvinyl alcohol-based foam material | |
| CN113019273A (en) | Fragrance sustained-release capsule and preparation method thereof | |
| RU2471824C1 (en) | Biocompatible, biodegradable porous composite material and method of producing said material | |
| JPH0622559B2 (en) | Porous chitin molding for hemostasis | |
| JPS62167331A (en) | Chitosan sponge | |
| CN116510062B (en) | A rapid hemostatic sponge reinforced with sea squirt nanocellulose and having photothermal antibacterial effect and its preparation method | |
| JPH02261838A (en) | Preparation of porous chitosan material | |
| JP2007197649A (en) | Sponge made of polysaccharide | |
| JP5703211B2 (en) | Sponge manufacturing method | |
| JPS6164256A (en) | Wound covering protective material |